Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low

Fig. 1

Investigations of clinical features in TNBC patients with different HER2 status. (A) Flow chart of study population enrollment. (B) Overall survival curves of HER2low and HER2neg TNBC patients diagnosed at our institution in the past seven years, using logrank test. P < 0.05 indicates statistical significance. The detailed survival data are attached in Additional file 8: Table S1. (C) Forest plots showing the prognostic effects of clinical features in all TNBC, HER2low, and HER2neg TNBC patients, respectively

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us